2021 Virtual KU Hematology and Medical Oncology Review

https://www.kucancercenter.org/

 

2021 Virtual KU Hematology and Medical Oncology Review
A

2021 KUMC Updates on Triple R/R MM: Does Ide-Cel Improve Overall Response?

By 2021 Virtual KU Hematology and Medical Oncology Review FEATURING Al-Ola Abdallah
By 2021 Virtual KU Hematology and Medical Oncology Review FEATURING Al-Ola Abdallah
15 views
July 22, 2021
Comments 0
Login to view comments. Click here to Login
Videos
43:11

2021 Advances in Metastatic Sarcoma: GIST & Ripretinib, Synovial Sar…

2021 Virtual KU Hematology and Medical Oncology Review

B. Van Tine

116 views
25:06

ASCO 2021 Survivorship Highlights: Remote Symptom Monitoring, Inpati…

2021 Virtual KU Hematology and Medical Oncology Review

E. Wulff-Burchfield

13 views
30:04

2021 Updates in HNSCC: Expert Overview of Recent Clinical Trials

2021 Virtual KU Hematology and Medical Oncology Review

B. Burtness

169 views
09:13

ASCO 2021 Updates in Head and Neck Cancers: Advanced NPC, HPV-Relate…

2021 Virtual KU Hematology and Medical Oncology Review

B. Burtness

40 views
18:15

KUMC Highlights on mCRC: Recent Data on Changes in the SoC

2021 Virtual KU Hematology and Medical Oncology Review

W. Sun

228 views
06:25

2021 KUMC Metastatic Prostate Cancer Updates: 177Lu-PSMA-617 in mCRP…

2021 Virtual KU Hematology and Medical Oncology Review

S. Abbasi

38 views
08:08

2021 Developments in RCC & UC: Pembro for ccRCC, Sacituzumab Govitec…

2021 Virtual KU Hematology and Medical Oncology Review

S. Abbasi

63 views
15:17

2021 Advances in CML: Prognostic Scores, Treatment Goals, 1L & Beyon…

2021 Virtual KU Hematology and Medical Oncology Review

A. Yacoub

118 views
05:01

2021 Advances in Myelofibrosis: Parsaclisib + Ruxolitinib Combinatio…

2021 Virtual KU Hematology and Medical Oncology Review

A. Yacoub

172 views
10:52

2021 KUMC NDMM Updates: Assessing Current Trials for Treatment, Indu…

2021 Virtual KU Hematology and Medical Oncology Review

A. Abdallah

93 views
07:17

2021 KUMC Updates on Triple R/R MM: Does Ide-Cel Improve Overall Res…

2021 Virtual KU Hematology and Medical Oncology Review

A. Abdallah

15 views
27:42

CAR T-Cell and CRISPR in Hematologic Malignancies: Continuing Revolu…

2021 Virtual KU Hematology and Medical Oncology Review

J. McGuirk

158 views
10:44

ASCO 2021 Highlights on TNBC: Durvalumab + Neoadjuvant Therapy in Ea…

2021 Virtual KU Hematology and Medical Oncology Review

Q. Khan

212 views
08:59

ASCO 2021 Review of the OlympiA Trial for High-Risk EBC: Do Adjuvant…

2021 Virtual KU Hematology and Medical Oncology Review

Q. Khan

291 views
10:17

ASCO 2021 Updates on De-Escalation Strategies in BC: Talazoparib for…

2021 Virtual KU Hematology and Medical Oncology Review

Q. Khan

71 views